Sarepta Therapeutics, Inc. (SRPT) vs Zymeworks Inc. (ZYME)
- Sarepta Therapeutics, Inc. SRPT 17.06 −4.10%
- Zymeworks Inc. ZYME 25.07 −2.64%
Sarepta Therapeutics, Inc. and Zymeworks Inc. are both Biotechnology companies. Sarepta Therapeutics, Inc. and Zymeworks Inc. are of similar size ($1.9B and $1.8B). Sarepta Therapeutics, Inc. grew revenue faster over the last twelve months: −20.4% against −69.8%. Sarepta Therapeutics, Inc. has the higher net margin (−6.93% vs −404.0%) and the lower return on invested capital (−5.64% vs 0.00%). Across the 18 metrics below, Sarepta Therapeutics, Inc. leads on 13 and Zymeworks Inc. on 5.
Valuation
Profitability
| Metric | SRPT | ZYME | Biotechnology median |
|---|---|---|---|
| Gross margin | 59.09% | (246.66%) | 65.16% |
| Operating margin | (7.26%) | (418.99%) | 0.00% |
| Net margin | (6.93%) | (404.00%) | 0.00% |
| Free cash flow margin | 3.80% | (324.68%) | 0.00% |
| Return on equity | (9.48%) | (72.31%) | (56.36%) |
| Return on assets | (3.98%) | (37.25%) | (48.04%) |
| Return on invested capital | (5.64%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack